Synthesis and characterization of the inclusion complex between repaglinide and sulfobutylether-β-cyclodextrin (Captisol®)

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 70, Issue 3-4, 2011, Pages 421-428

  Aramǎ, Corina ^a   Nicolescu, Camelia ^a   Nedelcu, Angela ^a   Monciu, Crina Maria ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Inclusion complex; Phase solubility; Repaglinide; Sulfobutylether cyclodextrin

Indexed keywords

EID: 80051716210     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-010-9911-4     Document Type: Conference Paper

References (20)

1. EMM Del Valle 2004 Cyclodextrins and their uses: a review Process. Biochem. 39 1033 1046 10.1016/S0032-9592(03)00258-9 1:CAS:528: DC%2BD2cXjtl2lurg%3D (Pubitemid 38527174)
2. Kurkov, S.V.; Ukhatskaya, E.V.; Loftsson, T.: Drug-cyclodextrin: beyond inclusion complexation. J. Incl. Phenom. Macrocycl. Chem. (2010). doi: 10.1007/s10847-010-9756-x
3. RL Carrier LA Miller I Ahmed 2007 The utility of cyclodextrins for enhancing oral bioavailability J. Control Release 123 78 99 10.1016/j.jconrel. 2007.07.018 1:CAS:528:DC%2BD2sXhtFyku7fI (Pubitemid 47566400)
4. ME Brewster T Loftsson 2007 Cyclodextrins as pharmaceutical solubilizers Adv. Drug Deliv. Rev. 59 7 645 666 10.1016/j.addr.2007.05.012 1:CAS:528:DC%2BD2sXpsFGks7g%3D (Pubitemid 47299263)
5. T Loftsson D Hreinsdottir M Masson 2005 Evaluation of cyclodextrin solubilization of drugs Int. J. Pharm. 302 1-2 18 28 10.1016/j.ijpharm.2005.05. 042 1:CAS:528:DC%2BD2MXpvVWju7w%3D (Pubitemid 41244817)
6. S Munoz-Botella M Martin DA Lerner 1996 Analytical applications of retinoid-cyclodextrin inclusion complexes J. Pharm. Biomed. Anal. 14 909 915 10.1016/0731-7085(95)01672-4 1:CAS:528:DyaK28Xks1Sjsr4%3D (Pubitemid 26235137)
7. J Szejtli 1984 High soluble beta-cyclodextrin derivatives Starch/Starke 36 12 429 432 10.1002/star.19840361207 1:CAS:528:DyaL2MXkslKmug%3D%3D
8. L Vica S Bota C Moisa M Ganea 2007 Evaluation study of the inclusion complex of captopril-β-cyclodextrin FARMACIA, LV 1 93 97
9. G Fronza A Mele E Redenti P Ventura 1992 Proton nuclear magnetic resonance spectroscopy studies of the inclusion complex of piroxicam with beta-cyclodextrin J. Pharm. Sci. 74 10 1162 1165 10.1002/jps.2600811206 (Pubitemid 23018119)
10. R Hodi Lj Tasic M Kata B Selmeczi Z Djuric 1991 Morphological study of products containing beta-cyclodextrin Starch/Starke 43 5 186 190 10.1002/star.19910430508 1:CAS:528:DyaK3MXksFOjtb0%3D
11. S Beni Z Szakacs O Csernak L Barcza B Noszal 2007 Cyclodextrin/imatinib complexation: Binding mode and charge dependent stabilities Eur. J. Pharm. Sci. 30 2 167 174 10.1016/j.ejps.2006.10.008 1:CAS:528:DC%2BD2sXpvVyiuw%3D%3D (Pubitemid 46157176)
12. Pickup, J.C.; Williams, G. (eds.): Textbook of Diabetes, vol. 1. Blackwell, Oxford (1996)
13. Z Mandić V Gabelica 2006 Ionization, lipophilicity and solubility properties of repaglinide J. Pharm. Biomed. Anal. 41 866 871 10.1016/j.jpba.2006.01.056
14. The Merck Index Online, Merck & Co.; Inc. (2009)
15. A Prameela Rani P Siva Teja N Archana C Bala Sekaran 2009 Phase solubility studies on antidiabetic drugs with β-cyclodextrin and HP-β-cyclodextrin Int. J. PharmTech Res. 1 1632 1637
16. C Nicolescu C Aramǎ CM Monciu 2010 Preparation and characterization of inclusion complexes between repaglinide and β-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and randomly methylated β-cyclodextrin Farmacia 58 1 78 88 1:CAS:528:DC%2BC3cXjsFyisLw%3D
17. C Nicolescu C Aramǎ A Nedelcu CM Monciu 2010 Phase solubility studies of the inclusion complexes of repaglinide with β-cyclodextrin and β-cyclodextrin derivatives Farmacia 58 5 620 628 1:CAS:528: DC%2BC3cXhsFWqtbzO
18. T Higuchi KA Connors 1965 Phase-solubility techniques Adv. Anal. Chem. Instrum. 4 117 122 1:CAS:528:DyaF2MXktlGitrg%3D
19. JJ Tang LJ Cline Love 1997 Formation constants of polynuclear aromatic compounds and β-cyclodextrin inclusion complexes in β-cyclodextrin modified mobile phase high performance liquid chromatography system Anal. Chim. Acta 344 137 143 10.1016/S0003-2670(96)00577-6 1:CAS:528:DyaK2sXislymu7g%3D (Pubitemid 27246613)
20. NFS de Melo R Grillo AH Rosa LF Fraceto 2008 Interaction between nitroheterocyclic compounds with β-cyclodextrins: phase-solubility and HPLC studies J. Pharm. Biomed. Anal 47 865 869 10.1016/j.jpba.2008.04.022